Principal Financial Group’s C4 Therapeutics CCCC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-13,238
| Closed | -$108K | – | 2383 |
|
|
2024
Q1 | $108K | Sell |
13,238
-1,515
| -10% | -$12.4K | ﹤0.01% | 2263 |
|
|
2023
Q4 | $83.4K | Buy |
14,753
+836
| +6% | +$4.72K | ﹤0.01% | 2289 |
|
|
2023
Q3 | $25.9K | Hold |
13,917
| – | – | ﹤0.01% | 2396 |
|
|
2023
Q2 | $38.3K | Buy |
13,917
+1,124
| +9% | +$3.09K | ﹤0.01% | 2378 |
|
|
2023
Q1 | $40.2K | Buy |
12,793
+1,428
| +13% | +$4.48K | ﹤0.01% | 2387 |
|
|
2022
Q4 | $67.1K | Buy |
+11,365
| New | +$67.1K | ﹤0.01% | 2344 |
|
|
2022
Q1 | – | Sell |
-6,570
| Closed | -$212K | – | 2552 |
|
|
2021
Q4 | $212K | Sell |
6,570
-1,536
| -19% | -$49.6K | ﹤0.01% | 2342 |
|
|
2021
Q3 | $362K | Buy |
8,106
+2,600
| +47% | +$116K | ﹤0.01% | 2256 |
|
|
2021
Q2 | $208K | Buy |
+5,506
| New | +$208K | ﹤0.01% | 2465 |
|